Laboratory Question for the Week of June 30, 2025
Bryan Nordley
June 30, 2025
If both low-risk and high-risk HPV types are performed in a single assay, how would we code?
If both low-risk and high-risk HPV types are performed in a single assay, how would we code?
When both tibial/peroneal arteries in both legs are treated for lower extremity revascularization, what modifiers would we report?
We are still confused about when to use or if to use the LT or RT modifier. Do you have a formula that we could apply based on a scenario?
Do you have any additional guidelines for modifiers LT and RT?
What is the procedure code when a specific antigen test is ordered as a diagnostic test based on a sign or symptom?
Can you provide more clarity for 37215?
When would we report modifiers LT and RT?
As a follow-up to last week’s question, if an embolic protection device cannot be used, which code do we report between the two?
Why is it important to distinguish between codes 81025 and 84703 when coding pregnancy tests?
What physician requirements are necessary to report code 88172?
When are codes 37215 and 37216 assigned?
Can codes 88311-88314 be billed individually?
Subscribe to receive our News, Insights, and Compliance Question of the Week articles delivered right to your inbox.
Subscribe to receive our News, Insights, and Compliance Question of the Week delivered right to your inbox.
Address: 5874 Blackshire Path, #13, Inver Grove Heights, MN 55076
Phone: (800) 252-1578
Email: support@medlearnmedia.com
Hours: 9am – 5pm CT
Copyright © 2025 MedLearn Publishing. Powered by MedLearn Media.
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24